IRadimed Corp. (IRMD)
96.00
-0.42
(-0.44%)
USD |
NASDAQ |
Jun 10, 16:00
96.18
+0.18
(+0.19%)
Pre-Market: 20:00
IRadimed Enterprise Value : 1.171B for June 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 1.171B |
| June 09, 2026 | 1.176B |
| June 08, 2026 | 1.150B |
| June 05, 2026 | 1.133B |
| June 04, 2026 | 1.140B |
| June 03, 2026 | 1.108B |
| June 02, 2026 | 1.092B |
| June 01, 2026 | 1.120B |
| May 29, 2026 | 1.103B |
| May 28, 2026 | 1.122B |
| May 27, 2026 | 1.118B |
| May 26, 2026 | 1.132B |
| May 22, 2026 | 1.121B |
| May 21, 2026 | 1.135B |
| May 20, 2026 | 1.099B |
| May 19, 2026 | 1.060B |
| May 18, 2026 | 1.075B |
| May 15, 2026 | 1.049B |
| May 14, 2026 | 1.054B |
| May 13, 2026 | 1.034B |
| May 12, 2026 | 1.027B |
| May 11, 2026 | 1.021B |
| May 08, 2026 | 1.047B |
| May 07, 2026 | 1.052B |
| May 06, 2026 | 1.046B |
| Date | Value |
|---|---|
| May 05, 2026 | 1.041B |
| May 04, 2026 | 1.029B |
| May 01, 2026 | 1.058B |
| April 30, 2026 | 1.010B |
| April 29, 2026 | 1.014B |
| April 28, 2026 | 1.024B |
| April 27, 2026 | 1.082B |
| April 24, 2026 | 1.077B |
| April 23, 2026 | 1.079B |
| April 22, 2026 | 1.096B |
| April 21, 2026 | 1.084B |
| April 20, 2026 | 1.132B |
| April 17, 2026 | 1.142B |
| April 16, 2026 | 1.118B |
| April 15, 2026 | 1.133B |
| April 14, 2026 | 1.140B |
| April 13, 2026 | 1.139B |
| April 10, 2026 | 1.138B |
| April 09, 2026 | 1.165B |
| April 08, 2026 | 1.188B |
| April 07, 2026 | 1.139B |
| April 06, 2026 | 1.166B |
| April 02, 2026 | 1.174B |
| April 01, 2026 | 1.178B |
| March 31, 2026 | 1.174B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 183.35M |
| IDEXX Laboratories, Inc. | 45.04B |
| Masimo Corp. | 9.791B |
| Neogen Corp. | 2.629B |
| QuidelOrtho Corp. | 3.654B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 5.818M |
| Revenue (Quarterly) | 21.98M |
| Total Expenses (Quarterly) | 16.16M |
| EPS Diluted (Quarterly) | 0.4521 |
| Gross Profit Margin (Quarterly) | 76.50% |
| Profit Margin (Quarterly) | 26.47% |
| Earnings Yield | 1.91% |
| Operating Earnings Yield | 2.26% |
| Normalized Earnings Yield | 1.912 |